Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime-Avibactam vs Cefepime in Children with cUTI
NCT02497781Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2015
- Primary completion
- Sep 2017
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 9
01
Overview
A Phase 2 trial of ceftazidime + avibactam in complicated urinary tract infection (cUTI), sponsored by Pfizer. Started Sep 2015; status: completed.
02
Drugs
ceftazidime + avibactam
03
Conditions
complicated urinary tract infection (cUTI)
Beyond the preview
Go deeper on NCT02497781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497781.